|
rs699
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Angiotensinogen M235T and T174M polymorphisms have individually been associated with elevated levels of plasma angiotensinogen, hypertension, and left ventricular hypertrophy.
|
17145981 |
2007 |
|
rs699
|
|
|
0.060 |
GeneticVariation |
BEFREE |
There are controversies concerning the association of angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism with left ventricular hypertrophy (LVH), and the unclear association between angiotensinogen (ATG) M235T polymorphism and LVH.
|
10646957 |
2000 |
|
rs699
|
|
|
0.060 |
GeneticVariation |
BEFREE |
These results suggest an association of combined angiotensin I-converting enzyme gene I/D polymorphism genotypes, and angiotensinogen gene M235T polymorphism genotypes with left ventricular hypertrophy due to long-term athletic training.
|
11737220 |
2001 |
|
rs699
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Polymorphism of the AGT M235T gene but not ACE I/D gene is associated with greater LVMi and relative wall thickness, indicating more concentric LVH, in Chinese peritoneal dialysis patients.
|
12675870 |
2003 |
|
rs699
|
|
|
0.060 |
GeneticVariation |
BEFREE |
The angiotensinogen T174M and M235T and the AT1-receptor A1166C polymorphisms were related to the change in LVH during antihypertensive treatment with an AT1-receptor antagonist; of these angiotensinogen T174M was the most powerful.
|
11910301 |
2002 |
|
rs699
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Angiotensinogen gene M235T polymorphism is associated with the variability in left ventricular hypertrophy induced by endurance training, with athletes homozygous for the T allele having the largest hearts.
|
10440164 |
1999 |
|
rs1267969615
|
|
|
0.050 |
GeneticVariation |
BEFREE |
Angiotensinogen gene M235T polymorphism is associated with the variability in left ventricular hypertrophy induced by endurance training, with athletes homozygous for the T allele having the largest hearts.
|
10440164 |
1999 |
|
rs1267969615
|
|
|
0.050 |
GeneticVariation |
BEFREE |
Polymorphism of the AGT M235T gene but not ACE I/D gene is associated with greater LVMi and relative wall thickness, indicating more concentric LVH, in Chinese peritoneal dialysis patients.
|
12675870 |
2003 |
|
rs1267969615
|
|
|
0.050 |
GeneticVariation |
BEFREE |
There are controversies concerning the association of angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism with left ventricular hypertrophy (LVH), and the unclear association between angiotensinogen (ATG) M235T polymorphism and LVH.
|
10646957 |
2000 |
|
rs1267969615
|
|
|
0.050 |
GeneticVariation |
BEFREE |
These results suggest an association of combined angiotensin I-converting enzyme gene I/D polymorphism genotypes, and angiotensinogen gene M235T polymorphism genotypes with left ventricular hypertrophy due to long-term athletic training.
|
11737220 |
2001 |
|
rs1267969615
|
|
|
0.050 |
GeneticVariation |
BEFREE |
The angiotensinogen T174M and M235T and the AT1-receptor A1166C polymorphisms were related to the change in LVH during antihypertensive treatment with an AT1-receptor antagonist; of these angiotensinogen T174M was the most powerful.
|
11910301 |
2002 |
|
rs397516005
|
|
|
0.040 |
GeneticVariation |
BEFREE |
Concentrations of branched chain amino acids, triglycerides and ether phospholipids were increased in mutation carriers with hypertrophy as compared to controls and non-hypertrophic mutation carriers, and correlated with echocardiographic LVH and signs of diastolic and systolic dysfunction in subjects with the MYBPC3-Q1061X mutation.
|
26267065 |
2015 |
|
rs397516005
|
|
|
0.040 |
GeneticVariation |
BEFREE |
We studied 140 carriers (G+) of the TPM1-Asp175Asn or MYBPC3-Gln1061X pathogenic variants for HCM: The G+/LVH+ group (n = 98) consisted of mutation carriers with LVH and the G+/LVH- group (n = 42) without LVH.
|
30497761 |
2019 |
|
rs397516005
|
|
|
0.040 |
GeneticVariation |
BEFREE |
Our objective was to measure the length of mitral valve leaflets by cardiovascular magnetic resonance (CMR) in subjects with HCM caused by a Finnish founder mutation in the myosin-binding protein C gene (MYBPC3-Q1061X), carriers of the same mutation without left ventricular hypertrophy, as well as in unselected consecutive patients with HCM, and respective controls.
|
27259862 |
2016 |
|
rs397516005
|
|
|
0.040 |
GeneticVariation |
BEFREE |
Septal convexity was significantly increased in subjects with the MYBPC3-Q1061X mutation and LVH (n = 32) compared to controls (11.4 ± 4.3 vs 2.7 ± 3.2 mm, P < 0.001).
|
30976029 |
2019 |
|
rs1801253
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Our data demonstrate that both Gly389Arg and Ser49Gly polymorphisms have very moderate influence on the risk of left ventricular hypertrophy and atrial fibrillation with no statistically significant effects on cardiac function and the development of cardiovascular complications.
|
24982877 |
2014 |
|
rs1801253
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Our findings show that the Arg389Gly polymorphism of the ADRB1 gene confers higher risk of left ventricular hypertrophy in human essential hypertension.
|
18298953 |
2008 |
|
rs1801253
|
|
|
0.030 |
GeneticVariation |
BEFREE |
The data suggest an association between the beta1AR Arg389Gly polymorphism and LVH, particularly the septal hypertrophy.
|
20731869 |
2010 |
|
rs4762
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Angiotensinogen M235T and T174M polymorphisms have individually been associated with elevated levels of plasma angiotensinogen, hypertension, and left ventricular hypertrophy.
|
17145981 |
2007 |
|
rs4762
|
|
|
0.030 |
GeneticVariation |
BEFREE |
1.The relationship between the angiotensinogen (AGT) T174M, angiotensin converting enzyme (ACE) insertion/deletion (I/D) and the angiotensin II type 1 receptor (AT1) genetic markers and left ventricular hypertrophy was examined in normal subjects and those with aortic stenosis.2.
|
8800593 |
1996 |
|
rs4762
|
|
|
0.030 |
GeneticVariation |
BEFREE |
The angiotensinogen T174M and M235T and the AT1-receptor A1166C polymorphisms were related to the change in LVH during antihypertensive treatment with an AT1-receptor antagonist; of these angiotensinogen T174M was the most powerful.
|
11910301 |
2002 |
|
rs5443
|
|
|
0.030 |
GeneticVariation |
BEFREE |
The GNB3 C825T gene polymorphism has recently been identified and associated with hypertension, obesity and left ventricular hypertrophy.
|
12566975 |
2003 |
|
rs5443
|
|
|
0.030 |
GeneticVariation |
BEFREE |
GNB3 825 C>T is likely to be a significant risk factor for LVH but not for EH in the Emirati population, thereby strengthening the view that LVH is genetically a separate clinical entity.
|
15614196 |
2005 |
|
rs5443
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Lack of association of G-protein subunit gene C825T polymorphism with left ventricular hypertrophy in essential hypertension.
|
12011775 |
2002 |
|
rs104894503
|
|
|
0.020 |
GeneticVariation |
BEFREE |
In HCM attributable to the Asp175Asn mutation in the alpha-tropomyosin gene, myocardial oxidative metabolism and FFA metabolism are increased and inversely related to LV hypertrophy at both the whole heart and regional level.
|
17556170 |
2007 |